Answer Addiction

Author: The Fix

  • Casey Affleck Opens Up About Ben's Alcoholism Struggle, Rehab Stay

    Casey Affleck Opens Up About Ben's Alcoholism Struggle, Rehab Stay

    “I think for his kids’ sake and for their mom, and for himself, he’s trying to do the work and get it together.”

    Actor and director Casey Affleck, brother of Ben Affleck, opened up about his brother’s ongoing struggle with alcohol, also revealing that it’s a family issue. He said that he and his brother “come from a long line of alcoholics.”

    “Ben is an addict and an alcoholic. Most of my grandparents are alcoholics. My father is an alcoholic, as bad as you can be, and he’s been sober for about 30 years,” Affleck, who is “about six years” sober, told ET.

    The Justice League star was admitted to a treatment facility in late August, with the support of estranged wife Jennifer Garner. The actor and director’s relapse attracted plenty of media attention as he sought treatment for the third time. Onlookers speculate that Affleck’s personal life, including a recent break-up, threw his recovery for a loop.

    His brother Casey says he is lucky to have “the kind of resources and time” to go to a good facility and get help.

    “It can’t be easier to have everybody looking at you and taking your picture as you’re walking out of an intervention. I don’t envy that. I saw my father struggle with it for many years and nobody was following him around with cameras and stuff,” said Casey. “It’s not a great look. But on the other hand, it’s nothing to be ashamed of and it’s good that he’s taken care of.”

    Ben sought treatment in 2001 and then in 2017. In March 2017 he released a statement via Facebook announcing that he had completed treatment for alcohol addiction.

    “I have completed treatment for alcohol addiction; something I’ve dealt with in the past and continue to confront,” he wrote. “I want to live life to the fullest and be the best father I can be. I want my kids to know there is no shame in getting help when you need it, and to be a source of strength for anyone out there who needs help but is afraid to take the first step.”

    His brother Casey says his family is the driving force of his recovery. “Alcoholism has a huge impact on not just the person, but also their family,” he told ET. “So, I think for his kids’ sake and for their mom, and for himself, he’s trying to do the work and get it together.”

    View the original article at thefix.com

  • Best Indie Films of 2018: The Fix Picks

    Best Indie Films of 2018: The Fix Picks

    In early recovery I had moments where I was sure I could not stay sober for one more minute. That’s when my friends offered sound advice: Don’t think, and go to movies.

    In early recovery I found myself inundated with obsessive worries scurrying around in my head. It was repetitive dark noise that I ached to shush with alcohol. At times I was sure that I could not stay sober for one more minute. That’s when my friends offered sound advice: “Don’t think, and go to movies.”

    So, as we head into fall with the looming Nov. 6 midterms, a real-life nail biter, let’s talk about the great escape—indies!

    This first film is an uplifting true story about an exceptional human being. He is a creative philanthropist with an unexpected approach to helping people with addiction and ex-cons who are way down on their luck.

    Skid Row Marathon is about a superior court judge in Los Angeles. Craig Mitchell is a one-man crusade helping addicts and ex-cons who live in tents and cardboard boxes on LA’s Skid Row. The worst part of his day job is sending criminals to prison. The compassionate judge came up with a way to have a positive impact. He gets the homeless back on their feet with a running club.

    Wife-and-husband team, Gabi and Mark Hayes, heard about the judge who trains the homeless to run marathons.

    Mark told The Fix. “Many of the homeless are on drugs—crack, heroin, crystal meth, alcohol, you name it. Gabi and I wanted to do something [to help]. My wife is the real runner. Me? I go kicking and screaming.”

    When the couple first approached Judge Mitchell about doing a documentary, Mark said Mitchell’s response was, “’You can’t just show up with a camera and start filming people at the lowest point of their lives.’”

    “The judge was right,” said Mark. “At first, some threw bottles at us. But we hung in there and put in the time to get to know them until they felt safe enough to speak to us. We were there to help, not exploit them.”

    The response to their film has been high praise and enthusiastic reviews.

    “I think [the film] resonates with so many audiences because people know everybody deserves a second chance,” said Gabi. “The homeless situation is heartbreaking and it keeps getting worse. More and more tents keep popping up and there are people lying in the streets. They just took a wrong turn in life.”

    Runners find purpose when they show up to run with the judge and are treated with respect. Their self-image improves which helps them to get off and stay off the drugs. Skid Row Marathon has raked in 21 awards at film festivals across America—including Best Director, Best Editing, and multiple audience awards. To find out how to see it, visit the website.

    For this next winner, it doesn’t matter if you weren’t born yet or if you can’t remember a thing about the 60s and 70s because you were too damn high. Any age is the right audience for this one.

    Nico, 1988 is about the last year in the life of German model-singer-actress Nico (neé Christa Päffgen). Her glory had faded long ago, as did her exquisite beauty. She looked ravaged beyond her years due to her 15-year heroin addiction. In one scene, Nico (Trine Dyrholm) is sharing a cigarette with a friend.

    “Am I ugly?” She asks. He jokingly replies: “Yeah. Really.”

    “Good,” she says. “I wasn’t happy when I was beautiful.”

    In her teens she was a model for Vogue and Elle which led to acting in a number of films. But Nico is best known as Andy Warhol’s muse and as a singer for the Velvet Underground. Lou Reed wrote the band’s revolutionary lyrics about heroin, prostitution, and sadism.

    In 2003, that first album ranked number 13 in Rolling Stone magazine’s “500 Greatest Albums of All Time.” If Nico had been alive to see that, she would not have been impressed.

    “I don’t need everybody to like me,” she says in the film. “I don’t care.”

    She says in the movie that Jim Morrison suggested that she form her own band. When asked if she’s disappointed that her band never had commercial success, she rasps “I hate the word commercial.”

    Smartly directed by Susanna Nicchiarelli, Nico, 1988 is a fiery and fascinating study of another rock and roll tragedy. Though there’s nothing glamorous about watching someone eaten away by drugs, it was a great reminder to stay sober. Don’t miss the explosive tour de force by Dryholm. It brings chills.

    After I gave up substances, I became aware of—and had to let go of—magical thinking. Ironically, my next pick is about two dreamers who built a fantastical world that sparkled like a disco ball:

    Studio 54

    In Manhattan, 254 West 54th Street was the place to be. Studio 54 opened in 1977 and it was a smash hit—a nightly revelry of drinking, drugging and disco dancing. We’re talking gobs of cocaine, mountains of Quaaludes, and A-listers. Everyone else had to wait outside hoping they would be allowed in.

    Owners Steve Rubell and Ian Schrager, two Jewish guys from Brooklyn, became great friends at Syracuse University. Rubell’s charisma was always on but Schrager avoided attention—until now. The 71-year-old finally told details from 40 years ago that nobody has ever heard. Director Matt Tyrnauer got his hands on loads of never-before-seen footage.

    The owners were not prepared for the club’s instant success. It became a haven for celebrating sex and drugs. You’ll see Rubell zipping around, spoiling his guests, flashing open a long coat to reveal a drugstore in pockets—a smorgasbord of chemical delights.

    Rubell paid steeply for his 24/7 bacchanal. So, although the flick triggered my euphoric recall—wild nights hoovering cocaine, glugging Bacardi and dancing all night—I also remember what it cost me. I’m lucky—I did survive, hey, hey.

    The following film is about an unusual triangle between a girl and a “good” mother (the only mom she’d known) and an alcoholic stranger that kicks off a psychodrama.

    Daughter of Mine (Figlia mia) is a fictional story set on the coast of Sardinia, Italy. Two women, adoptive-mom Tina (Valeria Golino) and alcoholic biological-mom Angelica (Alba Rohrwacher), compete for the love and attention of 10-year-old Vittoria (Sara Casu).

    The shy, fair-skinned, redheaded girl had no idea that she was adopted. Heavy drinker Angelica has a life that is totally unmanageable. She’s being kicked off a farm for not paying her bills, but before slinking out of town, this “bad” mom begs adoptive mom Tina to let her spend time with Vittoria. Tina, who is compassionate but wary, finally agrees. She thinks What’s the harm? Angelica will be gone soon.

    Vittoria, however, is enchanted by her wild birth mother that looks so much like her. As they bond, Tina’s anxiety skyrockets. The story is at times predictable but that doesn’t take away from its emotionality or the power of the acting.

    Italian director Laura Bispuri described it as “three characters who are all placed in a conflict that…breaks their heart.”

    The thoughtful, slower pace of a European indie is refreshing. The backdrop of rural Sardinia, with its cliffs, expansive sky and turquoise water, adds to the film’s richness. After the U.S. debut at Tribeca, Strand Releasing purchased this touching award-winner, which is now available on Netflix and DVD.

    This next indie won the top award at this year’s Tribeca Film Festival for Best Narrative Feature. It also won Best Screenplay and Best Cinematography. All prizes are well-deserved.

    Diane stars Mary Kay Place as a sad, retired widow (badly in need of Al-Anon, if you ask me) who exhausts herself by putting the needs of others first. Her mess-of-a-son Brian (Jake Lacy) is a man-child who’s in and out of rehabs and opiate stupors. It’s maddening to see what she puts up with. Both actors give industrial-super-strength performances, as does the rest of the cast which includes Estelle Parsons and Glynnis O’Connor. Diane is the first narrative feature for documentarian Kent Jones (Hitchcock/Truffaut) who wrote and directed. Jones is also Director of the New York Film Festival at Lincoln Center. Martin Scorsese is executive producer.

    Diane spends her days schlepping long distances, performing good deeds. She feeds the homeless at soup kitchens, visits sick friends, and tends to her dying cousin and the rest of the extended family. She meets her klatch of old friends for lunch, where she has angry outbursts (Oh, Diane! Get thee to Al-Anon). The actress is a master at comedic nuances. Her self-blame is a mystery until the satisfying reveal and her character’s profound spiritual arc. IFC bought the film. Theater release date to be announced.

     

    Mary Kay Place in Diane

    Next is an award-winning narrative feature from the UK. It’s got the right ingredients: excellent writing, directing, acting, and cinematography—all in the first sequence. Clever, subtle hints show the audience what they need to know about the year (2011), the place (London), and the protagonist.

    Obey is explosive. Nineteen-year-old Leon (Marcus Rutherford) has been gone for four years. He came home to care for his alcoholic mother (T’Nia Miller). But there is one condition: she has to stop drinking. The good news is that his father is gone. Bad news? His mother replaced Leon’s abusive dad with a creepy, scary boyfriend who enables her addiction.

    Leon likes to hang out with his friends, box at the gym, and inhale nitrous oxide from balloons. Things intensify when he meets the movie’s female lead, Twiggy (Sophie Kennedy Clark). She’s a blonde with big blue eyes and luscious full lips. Leon is transfixed but femme fatale Twiggy has a boyfriend. Leon’s tension builds. It’s all too much and he is going to blow. Leon hates his mother’s boyfriend and her alcoholism, and outside is the chaos of the 2011 London Riots. Director James Jones uses actual news footage seamlessly. To find out how to see it, visit the website.

    Blowin’ Up is a documentary about sex workers who are caught in the legal system. Many who end up in “the life” have substance use disorders. Director Stephanie Wang-Breal presents their gripping stories without judgment as the film zeroes in on an experimental program in a Queens court. The compassion in the film is its biggest strength. The heroes are an empathic team of women, including a judge and DA, who work diligently to help the workers find a new start. Counseling is used to help them fight their way off of drugs and out of the life-sucking cycle of turning tricks, getting arrested and seeing their lives circle the drain. This solution-oriented program offers a chance at redemption. The new approach toward an age-old problem appears to be working. It is inspiring and brings hope for America’s failing justice system where recidivism is commonplace.

    [Allison: What do you think of these 2 quick mentions as blurbs with internal links as a Sidebar?]

    Pssst. Don’t miss these options:

    Roll Red Roll is a documentary directed by Nancy Schwartzman. It tells the horrifying story of a sexual assault case that took place in Steubenville, Ohio. Male high-schoolers, clearly intoxicated, were caught on cell phone videos, laughing about raping a teenage girl while she was in and out of consciousness. Much of the town mocked her on social media and sided with the local boys. She was ridiculed for being drunk. It’s a powerful film that shines the light on how vulnerable one is when intoxicated. Crime blogger Alexandria Goddard broke the case. The hacking group Anonymous became involved in order to fight for justice. If you ask me, not enough justice was served.

    Read more: Roll Red Roll

    Jellyfish is a fictional story about Sarah Taylor (Liv Hill), an overburdened teenage girl living in Margate, a dreary seaside town in England. Her mother, Karen (Sinéad Matthews), stays in bed all day while Sarah rushes her younger siblings, boy and girl twins (Henry Lile and Jemima Newman) to school. Sarah pedals madly on a bicycle with the youngsters seated in a makeshift wooden trailer that’s hooked to the back. It’s a sad rickety setup that instantly conveys how poverty stricken they are.

    Read more: Jellyfish Captures the Reality of Growing Up with a Mentally Ill Parent

    View the original article at thefix.com

  • New Dosage Strength Of Opioid Addiction Drug Approved By FDA

    New Dosage Strength Of Opioid Addiction Drug Approved By FDA

    The FDA commissioner noted that the approval will expand access for patients and reduce drug development costs.

    The U.S. Food and Drug Administration (FDA) approved a new dosage strength for a maintenance drug for the treatment of opioid addiction.

    Cassipa, which is a sublingual (applied under the tongue) film that combines the opioid treatment drug buprenorphine and the opioid overdose reversal drug naloxone, will now be available in a 16 milligrams/4 milligrams dosage, and according to FDA Commissioner Scott Gottlieb, should be used in conjunction with counseling and therapy.

    The new dosage strength is approved by the FDA in both brand name and generic versions, and in various strengths.

    The approval underscores the agency’s emphasis on greater development of and access to medication-assisted treatment (MAT) for substance use disorder. The full range of MAT is a key element of the U.S. Department of Health and Human Services’ Five-Point Strategy to Combat the Opioid Crisis, and was the focus of guidelines issued to drug manufacturers for evaluating the effectiveness of new or existing MAT products. 

    In a statement issued in April 2018, Gottlieb described the FDA-approved MAT drugs—methadone, buprenorphine and naltrexone—as “safe and effective in combination with counseling and psychosocial support to stabilize brain chemistry [and] reduce or block the euphoric effects of opioids.”

    The FDA has also cited statistics from the Substance Abuse and Mental Health Services Administration (SAMHSA), which found that patients using MAT for opioid dependency have reduced their chance of overdose death by half.

    In addition to its suggested efficacy for opioid use disorder, Gottlieb noted that newer treatment options like the increased dosage strength for Cassipa will not only “broaden access for patients,” but may also “reduce drug development costs, so products may be offered at a lower price to patients” via the agency’s “streamlined approach to drug development for certain medication-assisted treatments that are based on buprenorphine.”

    This approach is the abbreviated 505(b)(2) pathway under the Federal Food, Drug and Cosmetic Act, which allows manufacturers to use the FDA’s findings regarding the safety of their product to grant approval.

    The FDA is advising that Cassipa should be used in conjunction with a complete treatment plan that includes counseling and other support, and should only be used after the patient is introduced to the drug and stabilized up to a dose of 16 mg of buprenorphine using another marketed product. Additionally, Cassipa can only be prescribed by Drug Addiction Treatment Act-certified prescribers.

    View the original article at thefix.com

  • Man Sentenced For Role In Amtrak Drug-Trafficking Ring

    Man Sentenced For Role In Amtrak Drug-Trafficking Ring

    The man helped direct the shipment of thousands of kilograms of heroin and cocaine from Los Angeles to Chicago. 

    A California man was hit with a 35-year prison sentence last week for his role in overseeing an international drug-running ring on Amtrak train lines, according to court records.

    Edgar Roque headed up the cocaine-dealing crew for at least six years, shipping thousands of kilograms of illicit drugs from Mexico across the United States.

    “This is criminal conduct of the worst kind,” federal prosecutor Paul H. Tzur wrote in a sentencing memorandum. “Edgar Roque’s leadership role directing the mass movement of heroin and cocaine into the Chicago area and elsewhere showed that he had absolutely no regard for the safety and well-being of addicts and the communities into which he delivered the drugs.”

    With at least 20 confederates—including men with names like “Lil Pimp” and “Traps”—Roque hauled in wholesale amounts of heroin and cocaine from cartel-level suppliers in Mexico, authorities said.

    After getting the drugs to California, Roque would have them shipped to Chicago where his accomplices would pick them up at Chicago’s Union Station and disperse them to stash houses across the Windy City. 

    After off-loading the goods, the lieutenants in Roque’s criminal circuit would hop on a commercial airline and fly the cash proceeds west, typically carrying $150,00 at a time.

    A multi-agency task force probed the underbelly of the organization for years, under the aegis of an investigation known as “Operation Derailed.”

    Months after the 32-year-old pleaded guilty to drug and money laundering charges, a federal judge on Tuesday sent him to prison. A number of Roque’s associates have either pleaded guilty or already been sentenced.

    Phillip Diaz netted more than 20 years in prison for helping ensure delivery of the drugs and maintaining bank accounts to launder the proceeds, prosecutors said.

    Anthony Koon of Colorado got nine years in prison for delivering almost 20 kilograms of heroin valued at around $1 million. Gerardo Sanchez of California helped launder the profits and accepted delivery of heroin to a Tinsley Park hotel room, which netted him a 17.5-year sentence. 

    Jorge Luis Ochoa-Canela was sentenced to five years behind bars for moving massive amounts of money back to suppliers. And Amtrak employee Roy Griffin netted an 18-month sentence for scheming to steal a package of cocaine arriving into Union Station. 

    Four other defendants have pleaded guilty and are scheduled for sentencing before the end of the year. 

    View the original article at thefix.com

  • Dealers Remain An Issue On Instagram Despite Crackdown Efforts

    Dealers Remain An Issue On Instagram Despite Crackdown Efforts

    The company is now working to make treatment options more readily visible as well with their new “Can we help?” pop-up.

    After repeatedly fielding allegations that their platforms helped fuel the opioid crisis, Facebook and Instagram are now taking extra steps to combat social media drug-selling and help divert users into treatment. 

    Last month Facebook announced plans to redirect drug-seeking social media users to a help box offering support suggestions and, months after blocking targeted hashtags, Instagram recently decided to take a similar approach. 

    “As part of Instagram’s commitment to be the kindest, safest social network, we’re launching a new pop-up within the app that offers to connect people with information about free and confidential treatment options, as well as information about substance use, prevention and recovery,” a spokesperson for the photo-sharing platform told TechCrunch in a statement.

    Social media community guidelines generally ban selling drugs online, but dealers have brazenly skirted those guidelines and the law, listing their goods online with relevant hashtags to attract would-be buyers.

    The growing trend sparked condemnation from Food and Drug Administration commissioner Scott Gottlieb earlier this year. 

    “Internet firms simply aren’t taking practical steps to find and remove these illegal opioid listings,” Gottlieb said in a speech at the National Rx Drug Abuse and Heroin Summit in April, according to Engadget. “There’s ample evidence of narcotics being advertised and sold online. I know that internet firms are reluctant to cross a threshold, where they could find themselves taking on a broader policing role. But these are insidious threats being propagated on these web platforms.”

    Instagram initially responded by shutting down potentially problematic search phrases like #fentanyl and #oxycontin—but dealers just shifted to unblocked hashtags instead.

    Then in August, Facebook took action by adding a “Can we help?” pop-up offering links for treatment referrals to anyone searching certain drug-related phrases like “buy OxyContin” or “buy Xanax.” At the same time, the company blocked words like “OxyContin” and “Xanax” from turning up any search results for Pages and Groups. (However, it’s still possible to find profile accounts with drugs included in the user name—such as the many users who simply list “Oxy Contin” as their names.) 

    Then in recent weeks, Instagram reevaluated its blocking-only approach.

    “Blocking hashtags has its drawbacks,” Instagram told TechCrunch. “In some cases, we are removing the communities of support that help people struggling with opioid or substance misuse.” 

    Although those blocked hashtags will stay blocked, now the company is working to make treatment options more readily visible as well with their new “Can we help?” pop-up.

    View the original article at thefix.com

  • Purdue Pharma Accused Of Targeting Seniors For Oxy Sales

    Purdue Pharma Accused Of Targeting Seniors For Oxy Sales

    The lawsuit claims Purdue had salespeople downplay the harmful risks and side effects of OxyContin.

    Oregon’s Department of Justice claims that pharmacy giant, Purdue Pharma, lied to the state and misled customers to drive sales.

    Oregon Attorney General Ellen Rosenblum filed a lawsuit against Purdue Pharma on Thursday, accusing the company of lying to the Oregon State Board of Pharmacy to obtain permission to sell in Oregon, as well as targeting senior citizens with its products.

    The violations against a settlement with Oregon goes back 10 years, according to a June 27 filing. Rosenblum’s office is demanding Purdue submit to the terms of a 2007 settlement or risk legal consequences.

    In the Thursday filing, Rosenblum’s office is demanding Purdue Pharma pay $1 million and abide by a prohibition against marketing to Oregon’s senior citizens.

    According to the lawsuit, Purdue released misleading publications and had its salespeople downplay the harmful risks and side effects of OxyContin, and specifically targeted disabled and senior citizens.

    Purdue also stands accused of lying in its application to renew its license to sell OxyContin in Oregon, erroneously claiming that the company had not faced state or federal punishment. In the past, they’ve been made to pay fines, and some of its top executives faced charges related to the company’s OxyContin marketing practices.

    “Ten years later, it is clear Purdue has flouted the judgment and ignored the severe federal penalties,” reads the lawsuit.

    Advocates for substance abuse prevention lauded the move, praising it as holding pharma companies accountable, to push them to cooperate in combating the opioid epidemic.

    “My hope is that this action will help establish some accountability and bring them to the table to help solve this,” said Dwight Holton, CEO of Lines for Life. “They ought to be helping us and they haven’t been.”

    Representatives of Purdue, however, disagree with this assessment of the situation.

    “We vigorously deny the state’s allegations,” said Purdue spokesperson Robert Josephson, according to the Oregonian. “The state claims Purdue acted improperly by communicating with prescribers about scientific and medical information that FDA has expressly considered and continues to approve. We believe it is inappropriate for the state to substitute its judgment for the judgment of the regulatory, scientific and medical experts at FDA. We look forward to presenting our substantial defenses regarding this lawsuit.”

    Working to improve its image in the shadow of the opioid crisis, Purdue has eliminated 350 sales positions, closed its “speakers” program that paid doctors and other professionals to sing OxyContin’s praises, and reshuffled its efforts towards researching cancer-fighting drugs.

    However, the opioid crisis has already damaged the state. Oregon saw a spike in opioid-related deaths in this past year, with Oregon’s Jackson County seeing a 70% increase in such deaths in just the first quarter of this year.

    View the original article at thefix.com

  • Juul Faces Criticism, Concerns Amid Rising Success

    Juul Faces Criticism, Concerns Amid Rising Success

    The company is accused of marketing its product to teens. 

    Arguably the most well-known e-cigarette on the market, Juul has seen skyrocketing sales in the past year, increasing 800%. But the success of the company isn’t without concern.

    According to CNBC, Juul founders James Monsees and Adam Bowen, both former smokers, initially started a company called Ploom, which later became known as Pax Labs. In 2015, they introduced Juul, a type of e-cigarette. Two years later, it broke off into its own company called Juul Labs.

    The team that initially created Juul was made up of about 20 people on a $2 million budget, CNBC states. Since then, the product has seen exponential growth. Today, the company is valued at $15 billion and makes up about 75% of the e-cigarette market.

    “What we realized is people don’t want a safer cigarette, they want to move past cigarettes,” Monsees told CNBC. “It’s hard to imagine an area that can be more powerful to public health in particular than to eliminate cigarettes from the face of the earth. It is one of the most successful consumer products of all time, if not the most successful, and yet it kills more than half of all people that use them long term. We always intended to build this company around the idea of making cigarettes obsolete. We knew Juul would be the way to do that.” 

    Juul contains about 40 milligrams of nicotine per cartridge. It works by vaporizing a liquid containing nicotine salts which is then inhaled by the user.

    “There’s a lot of misunderstanding about this category and about nicotine,” Bowen told CNBC. “Many people think that it’s deadly, a serious disease agent—when really alone, nicotine is quite benign. It’s a mild stimulant, and is habit-forming and can lead to dependence, and for that reason alone, no non-smoker should ever touch this product.”

    While Juul’s growth has been widely successful, it hasn’t been without obstacles. The company has faced various lawsuits, as well as new FDA regulations. 

    “If you’d have interviewed me two years ago, I’d have said they’re maybe 25% as dangerous as a cigarette,” Stanton Glantz, UCSF Center for Tobacco Control and Education Director, told CNBC. “Now, I think they’re somewhere between three-quarters as dangerous as a cigarette and as dangerous.” 

    A main criticism of the product is that it appeals to youth. One reason for this is that Juul comes in a variety of flavors. Additionally, it appears as compact as a flash drive, making it possible for kids to bring into schools without raising suspicions.

    “Kids who use them have more asthma, more days off school,” Glantz told CNBC. “There is evidence linking them with chronic obstructive pulmonary disease and other diseases. Addiction is not a phase, it’s not something kids grow out of.”

    Juul’s early marketing was also accused of being problematic due to making the product appealing to youth with its social media-based campaigns. Now, the company has shifted to marketing by using testimonials from adult users of the product.

    Both founders Monsees and Bowen say it’s important to focus on tobacco use prevention among youth, and have invested $30 million into that cause.

    Juul must submit its product to the FDA for review by August 2022.

    “We estimate we switched over a million smokers to Juul in just three years, but there are about 38 million left in the U.S. so there’s still a lot of room to grow,” Bowen told CNBC.

    Juul Labs released the following statement to The Fix: 

    JUUL Labs’ mission is to eliminate cigarette smoking by offering existing adult smokers with a better alternative to combustible cigarettes. JUUL is not intended for anyone else. We strongly condemn the use of our product by minors, and it is in fact illegal to sell our product to minors. No minor should be in possession of a JUUL product.

    Our goal is to further reduce the number of minors who possess or use tobacco products, including vapor products, and to find ways to keep young people from ever trying these products. We approach this with a combination of education, enforcement, technology and partnership with others who are focused on this issue, including lawmakers, educators and our business partners.

    Nicotine is addictive. An individual who has not previously used nicotine products should not start, particularly youth. Recent science raises serious concerns about the adverse effect of nicotine on adolescent neurodevelopment.

    We encourage parents to talk with their children about the dangers of nicotine. As a company we also continuously seek ways to contribute to this dialogue and knowledge base.

    View the original article at thefix.com

  • Ariana Grande’s Brother: Mac Miller Helped Me Get Sober

    Ariana Grande’s Brother: Mac Miller Helped Me Get Sober

    “He was the reason I went to the rehabilitation center where I was detoxed safely from all of the drugs alcohol and medications I was taking.”

    Frankie Grande paid tribute to Mac Miller in an Instagram post, stating it was thanks to the late rapper that Grande got sober.

    “I am beyond heartbroken over Malcolm’s death. He was a good friend and was wonderful to my sister,” Grande posed, referring to the relationship his sister, Ariana Grande, and Miller shared. “He was the reason I went to the rehabilitation center where I was detoxed safely from all of the drugs alcohol and medications I was taking, when I couldn’t imagine living without them. It was the place where I found the community of support that showed me that living life without drugs was a possibility and I would have never discovered that if it weren’t for Malcolm.”

    Grande went on to recount all the times Miller showed up to support Grande’s sobriety milestones before calling for sympathy for those who suffer from substance abuse disorders.

    “I am beyond heartbroken over Malcolm’s death. He was a good friend and was wonderful to my sister,” Grande wrote in the caption. “He was the reason I went to the rehabilitation center where I was detoxed safely from all of the drugs alcohol and medications I was taking, when I couldn’t imagine living without them. It was the place where I found the community of support that showed me that living life without drugs was a possibility and I would have never discovered that if it weren’t for Malcolm.”

    Grande recounted all of the times Miller showed up to celebrate his sobriety milestones, treating him with gifts and “words of encouragement.”

    “Addiction is a TERRIBLE disease… many people are suffering from addiction like I am and many many of them are losing,” he  wrote. “Those of us who are struggling with addiction must stay strong. We must continue to work HARD on ourselves every single day and help each other. Our disease is strong but WE ARE STRONGER and I vow to work every moment of my life to have myself sober so that i may be there for others.”

    Grande included several numbers to resources that anyone who may need help with substance abuse.

    “Malcolm my friend, you will be dearly missed,” he added. “And I know you will be looking down on me from heaven, proudAF for every day I live my life clean and sober… 453 days and counting… Thank you from the bottom of my heart.”

    View the original article at thefix.com

  • A Practical and Comprehensive Guide to Finding a Suboxone Clinic

    A Practical and Comprehensive Guide to Finding a Suboxone Clinic

    It took me 10 hours of phone calls, 20 voicemails, 3 chewed fingernails, and many packs of cigarettes before I found a Suboxone provider in my new town. This is the list I wish I had then.

    When I pulled a “geographic” a few years ago, leaving Portland for my home state of North Dakota, I underestimated the stress of starting over. In fact, stress isn’t a strong enough word to describe driving 1,300 miles with my recent ex-boyfriend in the passenger seat and the fear of restarting life without heroin; not to mention I had no full-time job prospect, no health insurance, no apartment, and very few of my possessions. I also had a unique fear that loomed over me like an ominous storm cloud: trying to find a new Suboxone* provider in a rural state. 

    It took me almost ten hours of phone calls, twenty voicemails, ten games of phone tag, three chewed fingernails, and many packs of cigarettes to find a clinic that would dispense the medicine I take to maintain my recovery. 

    Unfortunately, my situation is a common one. Despite our nation being in the throes of an opioid epidemic, finding a Suboxone provider is a widespread problem; only about one-third of addiction rehabilitation programs offer long-term use of methadone or buprenorphine (the active ingredient in Suboxone). And according to the National Alliance of Advocates for Buprenorphine Treatment (NAABT), only about half of all Suboxone providers are accepting new patients.

    Finding this life-saving medication shouldn’t be so hard. When you are committed to getting better, you shouldn’t have to worry about whether or not you’ll be able to find a clinic to dispense your medicine. A person with diabetes wouldn’t have to search hard to find insulin. So I’ve compiled a round-up of tips and suggestions. 

    This is the list I wish I’d had in early recovery:

    1. Find friends and family who are supportive of your Suboxone journey.

    2. Remember that your form of treatment is just as valid as all other types of treatment and recovery.

    Although Suboxone is a widely stigmatized and divisive medication in the recovery community, it has been shown to reduce opioid overdose death rates by 40 percent.

    3. Join online support groups and forums for people on Suboxone.

    Since I lived in a rural area, I couldn’t find any in person groups. So I joined secret social media Suboxone support groups on Facebook, recovery Reddit threads, and peer-support forums such as the Addiction Survivors website and Suboxone Talk Zone.

    4. Allow Plenty of Time to Research, Call, and Locate Providers.

    This was the most daunting and lengthy part of finding a new provider. Dr. Bruce Seligsohn has been a board-certified internist in Southern California for 30 years and practicing addiction medicine for 10 years. Dr. Seligsohn advises: “Patients really need to be very careful selecting a doctor if they have a choice. I would suggest that a patient looking for a new doctor do their due diligence and see what comes up online about the doctor.”

    I have compiled the most current resources available as of August 2018. See the sidebar for a sample phone script for calling providers.  

    Pros: Convenience, ease of navigation. You will be able to easily search for a provider based upon zip code, state, and the distance that you’re able to travel for a clinic.

    Cons: Out of date, inaccurate, not comprehensive. Be prepared for hours of phone calls depending on your location and financial situation. Not all providers are listed on the site. I also found that some of the clinics listed were not accepting new patients, had been closed, or had their numbers disconnected.

    Pros: Ease of navigation, instant results. Similar to the Suboxone manufacturer’s website, this is a good launching point for starting your search based upon zip code, state, and the distance that you’re able to travel. 

    Cons:  Not comprehensive and despite being a government resource, it is not up-to-date.

    Pros: Easy to use, more accurate. Treatment Match only connects you with providers in your area who are accepting new patients, reducing dead ends and calls to providers who aren’t accepting new patients or insurance. 

    Cons: Wait time/ lack of timeliness, not as many provider connections. This is not a straightforward directory and while it’s easy to sign up, you have to wait for a provider to respond to your email. The site claims that doctors respond 24/7, including weekends and holidays, but I only heard from them during normal business hours.

    • Yelp Reviews of Clinics

    Pros: Hearing directly from other patients about their experiences, easy to use, instantaneous, accessible.

    Cons: Questionable trustworthiness. Dr Seligsohn said: “Patient reviews can sometimes be very misleading.”

    • Calling Your Insurance Company

    Note: Insurance companies vary widely, so I can only speak from my experience. For example, in Oregon I was easily able to locate a Suboxone provider through my insurance company, but my North Dakota insurance did not provide referrals. They stated that their preferred addiction treatment was therapy and 12-step based treatment programs rather than medication.  

    Pros: Possible thorough list of doctors certified to prescribe Suboxone. Those Suboxone providers who accept your insurance are required to keep their information listed and up-to-date.

    Cons: Time-consuming and you have to deal with the hurdles of bureaucracy. Plus, some studies have found that only about 50% of eligible Suboxone doctors accept insurance. Some insurance companies like mine will allow you to submit an appeal asking them to cover part of your Suboxone visit or prescription, especially in rural areas. I saved all of my receipts and had my psychiatrist and Suboxone doctors write letters of support. After months of appeals, the insurance company agreed to cover part of each appointment. Each month I sent in a claim and receipt, and then I received a reimbursement check about a month later. 

    • Asking for a referral from your primary care provider, psychiatrist, or hospital.

    Another note: This is also difficult to give specific advice on because they vary depending according to location and providers, among many other factors.

    Pros: In-person support and assistance, more direct medical guidance and advice. 

    Cons: Stigma, lack of education about Suboxone, judgement, lack of timeliness. 

    5. Be Persistent!  

    6. Moving? Set Up an Appointment Months in Advance.

    Dr. Seligsohn advises finding a doctor and setting up an appointment prior to moving. “Patients need to find out as much information about how their perspective new doctor runs his practice…They also need to find out what the doctor’s philosophy is about long-term vs short-term Suboxone. If I was a patient I’d be reluctant to move to an area where there’s a shortage of Suboxone doctors.”


    Sidebar: Sample Phone Script for Calling Suboxone Providers

    I remember being so nervous, overwhelmed, and frustrated while also dealing with the symptoms of opioid withdrawal. Make sure you set aside a few hours for making calls in a quiet, safe place. I know some of these tips might seem like common sense, but when you’re in crisis and everything feels overwhelming, it can be a relief to have a guide.

    1. Introduce yourself and tell them that you’re looking for a suboxone provider.

    2. Where are you located?

    3. Are you accepting new patients?

    • If yes- when is your earliest available appointment?
    • If no- don’t hang up just yet! Ask: do you have a waiting list? Can you give me an estimate for how long it would take me to get an appointment? 
    • Do you have a cancellation list and if so, can you please add me to it?

    4. How often do I need to come to the clinic or office? 

    • Most clinics and offices require monthly or bi-monthly visits, but some require daily visits and dispense suboxone in a similar manner to methadone.

    4. Do you accept my insurance? 

    5. If the clinic does not accept insurance, how much does each appointment cost?

    • How much does the intake appointment/ first visit cost? This is an important question to ask because initial intake appointments can cost anywhere from $100 – $200 more than a regular visit.
    • Some clinics require pre-payment to reserve your appointment and prevent cancellation. Do you require a down payment before the appointment?
    • What forms of payment do you accept? (cash, credit, check?) Note that most clinics do not accept checks.
    • Do you allow payment plans or is payment due on the day of the appointment? A majority of clinics will not allow patients to do a payment plan and payment is due on the day of the appointment.
    • Are there any additional costs or required fees? Some charge additional fees for mandatory counseling, drug screens, etc.

    6. What are the counseling requirements?

    • You may be required to do weekly or monthly therapy groups with others at the clinic, and/or meet with an addiction counselor. This varies depending on how long you’ve been clean and your insurance coverage. (For example, one of my previous clinics had no counseling requirement, but my new clinic requires me to meet with an addiction counselor for one hour each month. Other clinics require weekly or bi-monthly group support meetings.)

    Quick Resource List:

    The Substance Abuse and Mental Health Administration (SAMHSA)’s Buprenorphine Treatment Practitioner Locator

    Suboxone Website’s Treatment Provider Directory

    Buprenorphine Matching System on Treatment Match on The National Alliance of Advocates for Buprenorphine Treatment (NAABT)

    Addiction Survivors

    Suboxone Talk Zone

      

    *(Writer’s Note: Suboxone is the most common brand-name buprenorphine medication, but this article is also applicable for patients seeking any form of buprenorphine treatment including: Subutex, Zubsolv, Bunavail, and Probuphine).  

    View the original article at thefix.com

  • Doctors Gave No Reason For Writing Opioid Scripts In Nearly 30% Of Cases

    Doctors Gave No Reason For Writing Opioid Scripts In Nearly 30% Of Cases

    A new study uncovered that doctors were prescribing opioids for hypertension and high cholesterol when no pain diagnosis was recorded. 

    A team at Harvard Medical School and the Rand Corp. combed through medical records from 2006 to 2015 and found that physicians gave no explanation for writing an opioid prescription in 29% of the cases.

    According to NBC News, the Centers for Disease Control and Prevention (CDC) has been working to get doctors to pull back on opioid prescriptions, citing careless prescribing as one cause of the opioid crisis. In 2016, more than 42,000 people died of opioid overdose, according to the CDC.

    The new study was led by Nicole Maestas, professor of health care policy at Harvard. Maestas and study coauthors went through tens of thousands of medical records, and then honed in on more than 31,000 physician surveys that included an opioid prescription.

    In two-thirds of the prescriptions, some type of pain diagnosis was present.

    The report, published in the Annals of Internal Medicine, then concluded, “No pain diagnosis was recorded at the remaining 28.5%.”

    “At visits with no pain diagnosis recorded, the most common diagnoses were hypertension, hyperlipidemia (high cholesterol), opioid dependence and ‘other follow-up examination,’” the research revealed.

    This over-prescribing could be unfairly impacting people who do have serious pain conditions and are finding it difficult to access the opioids they need to manage their pain due to new restrictions and doctors who fear that they will be targeted for over-prescribing.

    Dr. Tisamarie Sherry, who worked on the study, was reported in NBC News as emphasizing, “Whatever the reasons, lack of robust documentation undermines our efforts to understand physician prescribing patterns and curtails our ability to stem overprescribing.”

    The study also showed that 24% of youth who appeared with an opioid use disorder did not have a prescription to a medication-assisted treatment (MAT) drug to control their cravings.

    Drugs like buprenorphine and methadone are approved by the Food and Drug Administration for the treatment of opioid use disorder.

    “In this multistate study of addiction treatment and retention in care, we found that three-quarters of youths diagnosed with opioid use disorder received treatment within three months,” researchers wrote in JAMA Pediatrics. “However, most treatment included behavioral health services only, and fewer than one of four youths received timely buprenorphine, naltrexone or methadone treatment.”

    View the original article at thefix.com